Biologics: Targets and Therapy
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Dr Doris Mangiaracina Benbrook
ISSN: 1177-5491 (Online)
ISSN: 1177-5475 (Print)
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Article Processing Statistics:
14 From submission of manuscript to first editorial decision (including peer-review)
"I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University.
- Journal Indexing
See where all the Dove Press journals are indexed.
- MLA'14 -
May 16–21, 2014
- ISPOR International meeting
May 31 - June 4, 2014
- CINP World Congress
22 - 26 June, 2014
- Cancer Pharmacogenomics and Targeted Therapies
17 - 19 September, 2014
- ESMO 2014 Congress
26 - 30 September, 2014
- 27th ECNP Congress
18 - 21 October, 2014
- ISPOR 17th Annual European Congress 2014
8 - 12 November, 2014
Amsterdam, The Netherlands